Supporting patient groups and continuously improving knowledge in our therapy areas is part of our corporate responsibility.
Our ultimate goal is to discover and develop innovative therapies to improve patients' quality of life.
We specialize in the treatment of life-threatening diseases. Our patients always come first.
We offer programs for patients, families and patient organizations worldwide. They help to improve the quality of medical care.
Welcome to CSL Innovation GmbH, the Research & Development team in Marburg.
We actively promote collaborations and partnerships to bring innovation to patients.
At CSL Behring, we work every day as if someone’s life depends on it, because it does.
CSL Behring's biotherapeutics are manufactured in state-of-the-art facilities under strictly controlled conditions.
Help us deliver on our promise to save lives and protect the health of people.
We want you to feel comfortable at CSL.
Get to know us and learn more about people, projects and what happens in the world of CSL Behring.
Information for the press, such as press releases and press contact.
Popular search terms:
2025
Press conference in the new plasma center and castle illumination
We are delighted to welcome the eight new participants of the Re-Start Plus program at CSL Behring in Marburg!
At the M2U #FutureDay 2025 in Marburg, experts jointly developed groundbreaking ideas for the maintenance industry.
CSL reported net profit after tax of $2.04 billion in the first half of Fiscal Year 24/25.
On January 1, 2025, Christian Wieszner took over the position of second managing director of CSL Behring GmbH in Marburg.
Martin Vey succeeds Lars Grönke
Americas
Asia Pacific
Middle East
Europe
.jpg?h=900&w=1600&cropregion=0,0,6000,3376&hash=2264948A5420C478019764FD654ECB58)
